Transcriptome Study in Sicilian Patients with Huntington's Disease

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2025 Feb 26

PMID 40002561

Authors

Michele Salemi

Vincenzo Di Stefano

Francesca A Schillaci

Giovanna Marchese

Maria Grazia Salluzzo

Angela Cordella

Ilenia De Leo

Concetta Simona Perrotta

Giuseppe Nibali

Giuseppe Lanza

Raffaele Ferri

Affiliations

Soon will be listed here.

Abstract

: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of the CAG nucleotide repeat in the first exon of the huntingtin () gene. The disease typically manifests between the second and third decades of life and progresses gradually. The pathogenesis of HD involves the dysregulation of gene expression, influenced by various molecular processes ranging from transcription to protein stability. : To investigate potential variations in gene expression associated with HD, a transcriptome study was conducted using peripheral blood mononuclear cell samples from 15 HD patients and 15 controls, all of Sicilian origin. : The analysis identified 7179 statistically significant differentially expressed genes between the two groups. Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) terms were applied to identify the pathways affected by these differentially expressed mRNAs. The GSEA results highlighted significant associations between HD and GO pathways related to ribosomal functions and structure. These pathways were predominantly characterized by negative expression, with a substantial number of genes showing dysregulation. This suggests that the molecular processes leading to protein translation via ribosomes may be impaired in HD. Furthermore, dysregulation was observed in genes and non-coding RNAs involved in regulatory roles across various transcriptional processes. : These findings support the hypothesis that the entire process, from transcription to translation, is disrupted in HD patients carrying the CAG repeat expansion in the first exon of the gene.

References

Lee J, Hwang Y, Ryu H, Kowall N, Ryu H . Nucleolar dysfunction in Huntington's disease. Biochim Biophys Acta. 2013; 1842(6):785-90. PMC: 3972370. DOI: 10.1016/j.bbadis.2013.09.017. View

Tsoi H, Chan H . Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease. Cerebellum. 2013; 12(3):310-2. DOI: 10.1007/s12311-012-0447-6. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Boudreau R, McBride J, Martins I, Shen S, Xing Y, Carter B . Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Mol Ther. 2009; 17(6):1053-63. PMC: 2835182. DOI: 10.1038/mt.2009.17. View

Lee H, Fenster R, Pineda S, Gibbs W, Mohammadi S, Davila-Velderrain J . Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation. Neuron. 2020; 107(5):891-908.e8. PMC: 7486278. DOI: 10.1016/j.neuron.2020.06.021. View

Kim D, Rossi J . Strategies for silencing human disease using RNA interference. Nat Rev Genet. 2007; 8(3):173-84. DOI: 10.1038/nrg2006. View

Cho I, Clever F, Hong G, Chan A . CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington's Disease Monkeys. Biomedicines. 2022; 10(8). PMC: 9405741. DOI: 10.3390/biomedicines10081863. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Eshraghi M, Karunadharma P, Blin J, Shahani N, Ricci E, Michel A . Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. Nat Commun. 2021; 12(1):1461. PMC: 7935949. DOI: 10.1038/s41467-021-21637-y. View

10.

Tsoi H, Chan H . Roles of the nucleolus in the CAG RNA-mediated toxicity. Biochim Biophys Acta. 2013; 1842(6):779-84. DOI: 10.1016/j.bbadis.2013.11.015. View

11.

Kornberg R, Lorch Y . Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell. 1999; 98(3):285-94. DOI: 10.1016/s0092-8674(00)81958-3. View

12.

Aagaard L, Rossi J . RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev. 2007; 59(2-3):75-86. PMC: 1978219. DOI: 10.1016/j.addr.2007.03.005. View

13.

Li B, Carey M, Workman J . The role of chromatin during transcription. Cell. 2007; 128(4):707-19. DOI: 10.1016/j.cell.2007.01.015. View

14.

Matera I, Miglionico R, Abruzzese V, Marchese G, Ventola G, Castiglione Morelli M . A Regulator Role for the ATP-Binding Cassette Subfamily C Member 6 Transporter in HepG2 Cells: Effect on the Dynamics of Cell-Cell and Cell-Matrix Interactions. Int J Mol Sci. 2023; 24(22). PMC: 10670978. DOI: 10.3390/ijms242216391. View

15.

Tabrizi S, Flower M, Ross C, Wild E . Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020; 16(10):529-546. DOI: 10.1038/s41582-020-0389-4. View

16.

Prashad N, Rosenberg R . Comparison of ribosomal subunit proteins from normal human and Huntington's disease skin fibroblasts. Ann Neurol. 1977; 1(5):475-7. DOI: 10.1002/ana.410010512. View

17.

Andrade-Navarro M, Muhlenberg K, Spruth E, Mah N, Gonzalez-Lopez A, Andreani T . RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease. Front Neurol. 2020; 11:573560. PMC: 7731869. DOI: 10.3389/fneur.2020.573560. View

18.

Martin-Solana E, Diaz-Lopez I, Mohamedi Y, Ventoso I, Fernandez J, Fernandez-Fernandez M . Progressive alterations in polysomal architecture and activation of ribosome stalling relief factors in a mouse model of Huntington's disease. Neurobiol Dis. 2024; 195:106488. PMC: 7616275. DOI: 10.1016/j.nbd.2024.106488. View

19.

Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

20.

Miller J, Lo K, Andre R, Hensman Moss D, Trager U, Stone T . RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation. Hum Mol Genet. 2016; 25(14):2893-2904. PMC: 5181590. DOI: 10.1093/hmg/ddw142. View